A Case of Cutaneous Leishmaniasis Responding to Systemic Liposomal Amphotericin B Treatment

被引：0

作者：

Taskin, Esra Cakmak ^{[1
]}

Kutukcu, Hatice Busra ^{[2
]}

Konca, Hatice Kubra ^{[1
]}

Arga, Gul ^{[1
]}

Ozdemir, Halil ^{[1
]}

Akay, Bengu Nisa ^{[3
]}

Ciftci, Ergin ^{[1
]}

Ince, Erdal ^{[1
]}

机构：

[1] Ankara Univ, Tip Fak, Cocuk Sagligi & Hastaliklari Anabilim Dali, Cocuk Enfeksiyon Hastaliklari Bilim Dali, Ankara, Turkey

[2] Ankara Univ, Tip Fak, Cocuk Sagligi & Hastaliklari Anabilim Dali, Ankara, Turkey

[3] Ankara Univ, Tip Fak, Deri & Zuhrevi Hastaliklari Anabilim Dali, Ankara, Turkey

来源：

JOURNAL OF PEDIATRIC INFECTION | 2020年 / 14卷 / 04期

关键词：

Amphotericin B; cutaneous leishmania; meglumine antimoniate;

D O I：

10.5578/ced.69928

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Leishmania is a vector-induced endemic tropical disease caused by protozoans. The most common cutaneous, mucosal and visceral forms are the cutaneous form. The main drugs in treatment are pentavalent antimony compounds, but their side effects create limitation of use. Local antimony compounds are used primarily in the treatment of cutaneous leishmaniasis. In some cases, alternative treatment modalities are required due to insufficient response to local treatment. Systemic amphotericin B treatment is one of the alternative treatments. In a patient who developed cutaneous leishmania at 21 months and who did not respond with local meglumine antimoniate therapy, a total of 21 mg / kg dose of systemic amphotericin B was given intermittently and successful results were obtained.

引用

页码：247 / 250

页数：4

共 15 条

[1] Topical Amphotericin B for the treatment of localized cutaneous leishmaniasis [J].

Alcantara-Reifs, Carmen Maria ;

Garnacho-Saucedo, Gloria ;

Salido-Vallejo, Rafael ;

Velez Garcia-Nieto, Antonio .

DERMATOLOGIC THERAPY, 2017, 30 (01)

[2]

Bayazit Y., 2004, Turk Hijyen ve Deneysel Biyoloji Dergisi, V61, P9

[3]

Culha G, 2006, TURKIYE PARAZITOL DE, V30, P267

[4] Complete cure of a large complex cutaneous leishmaniasis with a nonethanolic lipid based-amphotericin B gel [J].

Gupta, A. ;

Sardana, K. ;

Ahuja, A. ;

Gautam, R. Kishan .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (07) :807-810

[5] Cutaneous and mucocutaneous leishmaniasis Differential diagnosis, diagnosis, histopathology, and management [J].

Handler, Marc Z. ;

Patel, Parimal A. ;

Kapila, Rajendra ;

Al-Qubati, Yasin ;

Schwartz, Robert A. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (06) :911-928

[6]

Kimberlin DW, 2018, RED BOOK 2018 2021 R, P501

[7] Rhinophyma-Like Cutaneous Leishmaniasis due to Leishmania aethiopica Treated Successfully with Liposomal Amphotericin B [J].

Kirchberger, Michael Constantin ;

Schliep, Stefan ;

Bogdan, Christian .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 100 (02) :231-232

[8] Microneedle-Based Delivery of Amphotericin B for Treatment of Cutaneous Leishmaniasis [J].

Nguyen, Alexander K. ;

Yang, Kai-Hung ;

Bryant, Kelsey ;

Li, Junan ;

Joice, April C. ;

Werbovetz, Karl A. ;

Narayan, Roger J. .

BIOMEDICAL MICRODEVICES, 2019, 21 (01)

[9]

OLMEZ D, 2007, DEU TIP FAKULTESI DE, V21, P97

[10]

Ser Onder, 2013, Turkiye Parazitoloji Dergisi, V37, P84, DOI 10.5152/tpd.2013.21

← 1 2 →